.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Teva
Farmers Insurance
Healthtrust
Colorcon
Novartis
Accenture
AstraZeneca
US Army
Harvard Business School

Generated: September 19, 2017

DrugPatentWatch Database Preview

FEXOFENADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Fexofenadine Hydrochloride, and when can generic versions of Fexofenadine Hydrochloride launch?

Fexofenadine Hydrochloride is a drug marketed by Dr Reddys Labs Ltd, Actavis Mid Atlantic, Teva, Barr, Mylan, Sciegen Pharms Inc, Wockhardt Ltd, Aurolife Pharma Llc, Sun Pharm Inds, Hetero Labs Ltd V, Sun Pharma Global, and Impax Pharms. and is included in sixteen NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Fifteen suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.

Summary for Tradename: FEXOFENADINE HYDROCHLORIDE

Patents:0
Applicants:12
NDAs:16
Suppliers / Packagers: see list68
Bulk Api Vendors: see list60
Clinical Trials: see list2,321
Patent Applications: see list1,268
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FEXOFENADINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: FEXOFENADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Ltd
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL079112-005Feb 8, 2012OTCNoNo► Subscribe► Subscribe► Subscribe
Barr
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL076236-001Apr 14, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL091567-005Feb 6, 2012OTCNoNo► Subscribe► Subscribe► Subscribe
Mylan
FEXOFENADINE HYDROCHLORIDE ALLERGY
fexofenadine hydrochloride
TABLET;ORAL077081-008Jul 21, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL079043-002Jun 22, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
FEXOFENADINE HYDROCHLORIDE ALLERGY
fexofenadine hydrochloride
TABLET;ORAL204097-002Aug 19, 2016OTCNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FEXOFENADINE HYDROCHLORIDE
fexofenadine hydrochloride
TABLET;ORAL076502-001Apr 11, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Sciegen Pharms Inc
FEXOFENADINE HYDROCHLORIDE ALLERGY
fexofenadine hydrochloride
TABLET;ORAL204507-003Sep 16, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Teva
FEXOFENADINE HYDROCHLORIDE ALLERGY
fexofenadine hydrochloride
TABLET;ORAL076447-008Apr 13, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
Sciegen Pharms Inc
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL204507-005Sep 16, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Chinese Patent Office
Boehringer Ingelheim
Mallinckrodt
Argus Health
Julphar
Teva
Daiichi Sankyo
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot